ANTIBACTERIAL ACTIVITY OF SAND CRAB (EMERITA ASIATICA) HEMOLYMPH AGAINST NILE TILAPIA (OREOCHROMIS NILOTICUS) INFECTED WITH AEROMONAS SALMONICIDA AND EDWARDSIELLA TARDA

Registration ID: IJNRD_197103

Published ID: IJNRD2305731

: Click Here to Get

R.Ronald Joshua, Ankesh Yadav, Jayanthi.J , Ragunathan M.G

Antibacterial, Hemolymph, Emerita asiatica, Edwardsiellatarda, Aeromonas salmonicida, Histopathology

Crustaceans have been identified as abundant sources of bioactive chemicals with promising uses in nutraceuticals and medicine. Since 1980s, the amount of fish produced worldwide has surged from 7% to nearly 40% and with a 6.3% share of the total global fish output, India now ranks second in the world for aquaculture production. Tilapias are the second most produced inland fish in the world, behind carps. The Nile tilapia is a species that is commonly cultivated because of its resilience to a variety of environmental circumstances, however one of the most significant elements influencing the success of Nile tilapia production is bacterial infections. Therefore, the hemolymph from Emerita Asiatica, a sand crab, was tested for its antibacterial properties. A sample of hemocoel from the Emerita Asiatica crab was taken, and the growth inhibition at various zones was used to examine the hemolymph's anti-bacterial properties. It was noticed that the Relative Percentage Survival (RPS) for the single and double immunisation groups against A. salmonicida and E. tarda were 60% and 100%, respectively, while for the combined group against both diseases, it was 34% and 100%. On healthy control subjects, a histological examination was performed to look at the structural changes in several organs, such as the kidney, liver, gills, and muscles. The treated fish displayed far fewer symptoms and reduced cellular damage to the organs, demonstrating the hemolymph's antibacterial action. Hence the present study revealed that Emerita Asiatica's haemolymph is a prospective source of very effective antibacterial agents and may be employed as a readily available natural immunostimulant material to combat bacterial infections in aquaculture.

Published Paper   E-Certificate

R.Ronald Joshua, Ankesh Yadav, Jayanthi.J , & Ragunathan M.G (May-2023). ANTIBACTERIAL ACTIVITY OF SAND CRAB (EMERITA ASIATICA) HEMOLYMPH AGAINST NILE TILAPIA (OREOCHROMIS NILOTICUS) INFECTED WITH AEROMONAS SALMONICIDA AND EDWARDSIELLA TARDA. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(5), h239-h255. https://ijnrd.org/papers/IJNRD2305731.pdf

Volume 8 Issue 5, May-2023

Pages : h239-h255

Paper Reg. ID: IJNRD_197103

Published Paper Id: IJNRD2305731

Downloads: 000121993

Research Area: Life Sciences 

Author Type: Indian Author

Country: Chennai, Tamil Nadu, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2305731.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2305731

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.

You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.

Call For Paper - Volume 10 | Issue 11 | November 2025

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.

For more details, refer to the official notice: UGC Public Notice

Submit Paper Online

Important Dates for Current issue

Paper Submission Open For: November 2025

Current Issue: Volume 10 | Issue 11 | November 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 30-Nov-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details

Approval, Licenses and Indexing: More Details